Admedus Ltd
ABN 35 088 221 078
5 December 2016
Centralised Company Announcements Platform Australian Stock Exchange
10th floor, 20 Bond Street Sydney NSW 2000
Dear Sir / Madam,
Appendix 3B - Share IssueREGISTERED OFFICE:
26 Harris Road Malaga Western Australia 6090
PO Box 6879
East Perth Western Australia 6892
T +61 (0)8 9266 0100
F +61 (0)8 9266 0199
E info.au@admedus.com www.admedus.com
The Board of Directors of Admedus Ltd hereby announces that the Company has completed a one and only allotment of 3,000,000 ordinary fully paid shares (to be held in escrow for a period of 12 months from the date of issue) pursuant to a confidential settlement of legal proceedings as announced on 9 September 2016 which resulted in the Company owning 100% of Admedus' regenerative tissue technology.
Refer to the attached Appendix 3B.
Yours sincerely
For and on behalf of Admedus Limited Maja McGuire Company SecretaryRule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreementInformation or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX's property and may be made public.
Introduced 01/07/96 Origin: Appendix 5 Amended 01/07/98, 01/09/99, 01/07/00, 30/09/01, 11/03/02, 01/01/03, 24/10/05, 01/08/12
Name of entity |
ADMEDUS LIMITED |
ABN |
35 088 221 078 |
We (the entity) give ASX the following information.
Part 1 - All issuesYou must complete the relevant sections (attach sheets if there is not enough space).
1 | +Class of +securities issued or to be issued | Ordinary fully paid shares |
2 | Number of +securities issued or to be issued (if known) or maximum number which may be issued | 3,000,000 |
3 | Principal terms of the +securities (eg, if options, exercise price and expiry date; if partly paid +securities, the amount outstanding and due dates for payment; if +convertible securities, the conversion price and dates for conversion) | Ordinary fully paid shares ranking equally with existing shares. The shares will be released from escrow 12 months after the date on which they were issued. |
4 | Do the +securities rank equally in all respects from the date of allotment with an existing +class of quoted +securities? If the additional securities do not rank equally, please state:
| Yes |
5 | Issue price or consideration | Nil monetary consideration. |
6 | Purpose of the issue (If issued as consideration for the acquisition of assets, clearly identify those assets) | Issued pursuant to a confidential settlement of the legal proceedings as announced on 9 September 2015 which resulted in the Company owning 100% of Admedus' regenerative tissue technology. |
6a | Is the entity an +eligible entity that has obtained security holder approval under rule 7.1A? If Yes, complete sections 6b - 6h in relation to the +securities the subject of this Appendix 3B, and comply with section 6i | Yes |
6b | The date the security holder resolution under rule 7.1A was passed | 10 November 2016 |
6c | Number of +securities issued without security holder approval under rule 7.1 | N/A |
6d | Number of +securities issued with security holder approval under rule 7.1A | N/A |
6e | Number of +securities issued with security holder approval under rule 7.3, or another specific security holder approval (specify date of meeting) | N/A | |
6f | Number of securities issued under an exception in rule 7.2 | N/A | |
6g | If securities issued under rule 7.1A, was issue price at least 75% of 15 day VWAP as calculated under rule 7.1A.3? Include the issue date and both values. Include the source of the VWAP calculation. | N/A | |
6h | If securities were issued under rule 7.1A for non-cash consideration, state date on which valuation of consideration was released to ASX Market Announcements | N/A | |
6i | Calculate the entity's remaining issue capacity under rule 7.1 and rule 7.1A - complete Annexure 1 and release to ASX Market Announcements | Listing Rule 7.1 capacity: 34,760,204 Listing Rule 7.1A capacity: 25,173,469 | |
7 | Dates of entering +securities into uncertificated holdings or despatch of certificates | 1 December 2016 | |
Number | +Class | ||
8 | Number and +class of all +securities quoted on ASX (including the securities in section 2 if applicable) | 254,734,693 | Ordinary Shares |
Admedus Ltd. published this content on 05 December 2016 and is solely responsible for the information contained herein.
Distributed by Public, unedited and unaltered, on 05 December 2016 02:28:08 UTC.
Original documenthttp://clients2.weblink.com.au/clients/admedus/article.asp?asx=AHZ&view=6802487
Public permalinkhttp://www.publicnow.com/view/2AAC16D365E1453B384C0CDB5E03E2A1C771A869